Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit
Landmark deal covers about 76,000 claims and could end contentious, decade-long legal battleJohnson & Johnson said it would pay an estimated $5.5bn to resolve tens of thousands of lawsuits alleging its baby powder and other talc products caused ovarian cancer, in a landmark deal that could end a contentious, decade-long legal battle.Johnson & Johnson on Monday said the settlement covers about 76,000 claims, including ones consolidated in a federal court in New Jersey, and related cases in state court, representing nearly all of the remaining talc claims against the company.
Reported by 1 outlet — The Guardian US. See all sources ↓
Read the full report at The Guardian US ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- Landmark deal covers about 76,000 claims and could end contentious, decade-long legal battleJohnson & Johnson said it would pay an estimated $5.5bn to resolve tens of thousands of lawsuits alleging its baby powder and other talc products caused ovarian cancer, in a landmark deal that could end a contentious, decade-long legal battle.Johnson & Johnson on Monday said the settlement covers about 76,000 claims, including ones consolidated in a federal court in New Jersey, and related cases in state court, representing nearly all of the remaining talc claims against the company.
- How widely is it covered?
- 1 outlet, average source rating 8.0/10.
- When was it last updated?
- 1d ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit
Sources1TypeCoverageThe Guardian US